With health authorities in the UAE keen to collaborate with global institutions for knowledge-transfer and high-quality care to patients, India has emerged as one of the top contenders thanks to its deep-rooted relations, the coronavirus and the ensuing synergy in the medical sector. This has the ingredients for a blossoming strategic partnership between the two countries.
As three separate trials play out in the next few weeks and months, the success of a home-grown Covid-19 vaccine will make access easy and affordable in India and around the world.
When the world emerges from the Covid-19 crisis there will be a greater need to improve and upgrade healthcare infrastructure. And Indian healthcare companies will have a lot to offer Africa in that respect.
A new manufacturing deal with Mumbai-headquartered global pharma and biotech giant Wockhardt’s Welsh subsidiary reflects yet another booster for the UK’s Covid-19 vaccine access drive.
Provision of accessible healthcare is not a consequence but a pre-requisite for economic growth, insists Abhay Soi, Chairman of Max Healthcare Institute.
The dearth of healthcare products and medical supplies needed by the world to fight the ongoing crisis has been fueling news headlines everywhere.
The futuristic vision of 2015 turns into reality as a cluster of cities lead the country’s fightback through innovative use of AI, Internet of Things, tele-health and unified data dashboards.